A family of novel TEAD palmitoylation site inhibitors with exceptional pre-clinical anti-neoplastic activity as a monotherapy and in combination with MAPK inhibitors
Florian L. Müller, D. Warshaviak, J. Gyuris, R. Nir et autres
0 citationsEuropean Journal of Cancer